HIBA PHARMA

000

KEZAD, Abu Dhabi

Est. 2021

About HIBA Pharma

Our Story

Advancing Life-Saving Therapies for a Global Need

Founded with a singular purpose — to bridge the gap in oncology pharmaceutical access across the UAE and MENA region — HIBA Pharma has grown from vision to a fully operational world-class manufacturing facility in under five years.

Mission

What Drives Us

At Hiba Pharma, we are committed to excellence in oncology pharmaceutical manufacturing. Through cutting-edge technology, rigorous quality standards, and innovative research, we develop life-saving cancer treatments that improve patient outcomes. With a focus on precision, compliance, and accessibility, we strive to set new benchmarks in oncology care. Our mission is clear: to advance pharmaceutical quality and enrich lives by providing safe, effective, and reliable therapies for those who need them most.

Our Mission

We believe that life-saving therapies should not be constrained by geography or supply chain fragility. HIBA Pharma's integrated manufacturing capability exists to solve exactly that problem — for the UAE, the GCC, and the world beyond.

Values

Precision

Every milligram matters. Our manufacturing processes are engineered to the highest accuracy tolerances.

Integrity

Regulatory compliance and ethical operations are non-negotiable at every level of our business.

Partnership

We believe the most important pharmaceutical challenges are solved through deep collaboration.

Impact

We measure success by patient outcomes and access improvements, not just commercial metrics.

Our Journey

From Vision to World-Class Manufacturing

2021Milestone

UAE Operations Launched

Launched UAE-based operations with a strategic focus on specialty oncology pharmaceutical manufacturing.

2022

Dubai Science Park Headquarters

Established business and R&D headquarters at Dubai Science Park, positioning HIBA at the heart of the UAE's innovation ecosystem.

2023Milestone

Strategic Licensing Agreements

Secured landmark Licensing & Technology Transfer agreements with Kelix Bio and Novugen Pharma. Groundbreaking ceremony in KEZAD, Abu Dhabi.

2024

Construction & Expansion

Licensing & Technology Transfer agreement with SAKAR Healthcare. Civil and structural construction progresses on schedule in KEZAD.

2025

MEP & Commissioning

Mechanical, Electrical & Plumbing systems installed and commissioned across all production and clean-room zones.

2026Milestone

Facility Inauguration

Official facility inauguration with EDE cGMP regulatory approval granted. HIBA Pharma enters full production-ready status.

2027Milestone

GMP Certifications

Technology transfer phase completion. GMP inspections for GCC and SFDA regulatory markets underway.